The influence of lung function and muscular strength on the functional capacity of chronic obstructive pulmonary disease patients;Influência da função pulmonar e da força muscular na capacidade funcional de portadores de doença pulmonar obstrutiva crónica

Revista Portuguesa de Pneumologia

Volumn 15, Issue 2, 2009, Pages 199-214

  Rodrigues, Sérgio Leite ^a,b   e Silva, César Augusto Melo ^a   Lima, Tereza ^a   de Assis Viegas, Carlos Alberto ^a   Rodrigues, Marcelo Palmeira ^a   Ribeiro, Fernanda Almeida ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b NONE   (Brazil)

Author keywords

COPD; Hypoxaemia; Muscle strength; Musculoskeletal system; Pulmonary rehabilitation; Six minute walk test

Indexed keywords

ADULT; AGED; ARTERIAL BLOOD; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HUMAN; HYPOXEMIA; LUNG FUNCTION; MALE; MUSCLE FUNCTION; MUSCLE STRENGTH; OXIMETRY; PHYSICAL PERFORMANCE; PULMONARY REHABILITATION; QUADRICEPS FEMORIS MUSCLE; SPIROMETRY; WALKING; ANOXIA; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY;

OXYGEN;

AGED; AGED, 80 AND OVER; ANOXIA; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 67650340645     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30127-6     Document Type: Article

References (30)

1. Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD, et al. Idiopathic pulmonary fibrosis prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006; 174(7):803-9.
2. Deboeck G, Niset G, Vachiery JL, Moraine JJ, Naeije R. Physiological response to the six-minute walk test in pulmonary arterial hypertension. Eur Respir J 2005; 26(4):667-72.
3. Gerbase MW, Spiliopoulos A, Rochat T, Archinard M, Nicod LP. Health-related quality of life following single or bilateral lung transplantation. A 7 year comparison to functional outcome. Chest 2005;128(3):1371-78.
4. Opasich C, De Feo S, Pinna GD, Furgi G, Pedretti R, Scrutinio D, et al. Distance walked in the 6-minute test soon after cardiac surgery. toward an efficient use in the individual patient. Chest 2004;126(6):1796-801.
5. Carter R, Holiday DB, Nwasuruba C, Stocks J, Grothues C, Tiep B. 6-minute walk work for assessment of functional capacity in patients with COPD. Chest 2003;123(5):1408-15.
6. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001;119(1):256-70.
7. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. GOLD Executive Summary. Am J Respir Crit Care Med 2007;176(6):532-55.
8. Ziegler B, Rovedder PME, Lukrafka JL, Oliveira CL, Menna -Barreto SS, Dalcin PTR. Capacidade submáxima de exercício em pacientes adolescentes e adultos com fibrose cística. J Bras Pneumol 2007;33(3):263-69.
9. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(4):1005-12.
10. Bowen JB, Votto JJ, Thrall RS, Haggerty MC, Stockdale-Woolley R, Bandyopadhyay T, et al. Functional status and survival following pulmonary rehabilitation. Chest 2000;118(3):697-703.
11. Casanova C, Cote CG, Marin JM, De Torres JP, Aguirre-Jaime A, Mendez R, et al. The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J 2007;29(3):535-40.
12. Dourado VZ, Tanni SE, Vale SA, Faganello MM, Sanchez FF, Godoy I. Manifestações sistêmicas na doença pulmonar obstrutiva crônica. J Bras Pneumol 2006;32(2):161-71.
13. Maltais F, Jobin J, Sullivan MJ, Bernard S, Whitton F, Killian KJ, et al. Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol 1998;84(5):1573-80.
14. Bigard AX, Sanchez H, Birot O, Serrurier B. Myosin heavy chain composition of skeletal muscles in young rats growing under hypobaric hypoxia conditions. J Appl Physiol. 2000;88(2):479-86.
15. Krieger, AC. Perturbação respiratória durante o sono em doença pulmonar obstrutiva crônica. J Bras Pneumol 2005;31(2):162-72.
16. Lung function testing: Selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991;144(5):1202-18.
17. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal expiration flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127(6):725-34.
18. Gosselin N, Durand F, Poulain M, Lambert K, Ceugniet F, Préfaut C, et al. Electrophysiologic changes during exercise testing in patients with chronic obstructive respiratory disease. Muscle Nerve 2003;27(2):170-9.
19. American Thoracic Society. ATS statement: guidelines for six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-7.
20. Dourado VZ, Antunes LCO, Tanni SE, Paiva SAR, Padovani CR, Godoy I. Relationship of upper-limb and thoracic muscle strength to 6-min walk distance in COPD patients. Chest 2006;129(3):551-7.
21. Rodrigues SL, Viegas CAA. Estudo de correlação entre provas funcionais respiratórias e o teste de caminhada de seis minutos em pacientes portadores de doença pulmonary obstrutiva crônica J Pneumol 2002; 28(6):324-8.
22. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego BA, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163(6):1395-9.
23. Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, Hayot M, et al. Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax 2005;60(10):834-41.
24. Mulloy E, Fitzpatrick M, Bourke S, O'Regan A, McNicholas WT. Oxygen desaturation during sleep and exercise in patients with severe chronic obstructive pulmonary disease. Respir Med 1995;89(3):193-8.
25. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary rehabilitation joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007;131(5):4S-42S.
26. Soler-Cataluña JJ, Sánchez-Sánchez L, Martínez -García MA, Sánchez PR, Salcedo E, Navarro M. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest 2005;128(4):2108-15.
27. Bernard S, Leblanc P, Whittom F, Jobin J, Belleau R, Bérubé C, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158(2):629-34.
28. Mador MJ, Bozkanat E, Aggarwal A, Shaffer M, Kufel TJ. Endurance and strength training in patients with COPD. Chest 2004;125(6):2036-45.
29. Clark CJ, Cochrane LM, Mackay E, Paton B. Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training. Eur Respir J 2000;15(1):92-7.
30. Spruit MA, Gosselink R, Troosters T, De Paepe K, Decramer M. Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J 2002;19(6):1072-8.